Page 58 - Demo

Chapter 256117. Hoytema van Konijnenburg EMM, Wortmann SB, Koelewijn MJ, et al. Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app. Orphanet J Rare Dis. Apr 12 2021;16(1):170. doi:10.1186/s13023-021-01727-2118. Ebrahimi-Fakhari D, Van Karnebeek C, Münchau A. Movement Disorders in Treatable Inborn Errors of Metabolism. Mov Disord. May 2019;34(5):598-613. doi:10.1002/mds.27568119. Overwater IE, Rietman AB, van Eeghen AM, de Wit MCY. Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives. Ther Clin Risk Manag. 2019;15:951-955. doi:10.2147/tcrm.S145630120. Tufekcioglu Z, Cakar A, Bilgic B, Hanagasi H, Gurvit H, Emre M. Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism. Neurocase. Jun 2016;22(3):273-5. doi:10.1080/13554794.2016.1142567121. Magrinelli F, Balint B, Bhatia KP. Challenges in Clinicogenetic Correlations: One Gene - Many Phenotypes. Mov Disord Clin Pract. Apr 2021;8(3):299-310. doi:10.1002/mdc3.13165122. Manti F, Nardecchia F, Barresi S, et al. Neurotransmitter trafficking defect in a patient withclathrin (CLTC) variation presenting with intellectual disability and early-onset parkinsonism. Parkinsonism Relat Disord. Apr 2019;61:207-210. doi:10.1016/j.parkreldis.2018.10.012